- Home
- ALLT vs ABEO Comparison
ALLT vs ABEO Comparison
Compare ALLT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- ABEO
- Stock Information
- Founded
- ALLT 1996
- ABEO N/A
- Country
- ALLT Israel
- ABEO United States
- Employees
- ALLT N/A
- ABEO N/A
- Industry
- ALLT Telecommunications Equipment
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- ABEO Health Care
- Exchange
- ALLT Nasdaq
- ABEO Nasdaq
- Market Cap
- ALLT 229.8M
- ABEO 237.4M
- IPO Year
- ALLT 2006
- ABEO 1980
- Fundamental
- Price
- ALLT $5.53
- ABEO $4.45
- Analyst Decision
- ALLT Buy
- ABEO Strong Buy
- Analyst Count
- ALLT 1
- ABEO 5
- Target Price
- ALLT $13.00
- ABEO $17.00
- AVG Volume (30 Days)
- ALLT 565.5K
- ABEO 493.1K
- Earning Date
- ALLT 05-28-2025
- ABEO 03-20-2025
- Dividend Yield
- ALLT N/A
- ABEO N/A
- EPS Growth
- ALLT N/A
- ABEO N/A
- EPS
- ALLT N/A
- ABEO N/A
- Revenue
- ALLT $92,195,000.00
- ABEO N/A
- Revenue This Year
- ALLT $6.43
- ABEO N/A
- Revenue Next Year
- ALLT $5.83
- ABEO $561.86
- P/E Ratio
- ALLT N/A
- ABEO N/A
- Revenue Growth
- ALLT N/A
- ABEO N/A
- 52 Week Low
- ALLT $1.99
- ABEO $3.05
- 52 Week High
- ALLT $9.44
- ABEO $8.45
- Technical
- Relative Strength Index (RSI)
- ALLT 40.14
- ABEO 26.67
- Support Level
- ALLT $5.45
- ABEO $4.95
- Resistance Level
- ALLT $7.00
- ABEO $5.14
- Average True Range (ATR)
- ALLT 0.42
- ABEO 0.25
- MACD
- ALLT 0.03
- ABEO -0.05
- Stochastic Oscillator
- ALLT 14.04
- ABEO 2.50
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.